US3169967A
(en)
|
1957-11-14 |
1965-02-16 |
Ciba Geigy Corp |
Methyl o-lower alkanoyl-reserpates
|
US3037980A
(en)
|
1955-08-18 |
1962-06-05 |
Burroughs Wellcome Co |
Pyrrolopyrimidine vasodilators and method of making them
|
DE1770420U
(de)
|
1958-02-27 |
1958-07-17 |
Tara Union G M B H |
Blumentopf aus kunststoff.
|
US3506643A
(en)
|
1966-12-09 |
1970-04-14 |
Max Thiel |
N**6-aralkyl-adenosine derivatives
|
DE2139107A1
(de)
|
1971-08-04 |
1973-02-15 |
Merck Patent Gmbh |
Heterocyclisch substituierte adenosinverbindungen
|
US3814251A
(en)
|
1972-08-09 |
1974-06-04 |
Sperry Rand Corp |
Power transmission
|
US3962443A
(en)
|
1972-08-14 |
1976-06-08 |
Dainippon Pharmaceutical Co., Ltd. |
Antibacterial pharmaceutical compositions and processes for preparation thereof
|
DE2248232A1
(de)
|
1972-10-02 |
1974-04-11 |
Basf Ag |
4-thiopyrimido eckige klammer auf 4,5-d eckige klammer zu pyrimidine
|
AR204003A1
(es)
|
1973-04-03 |
1975-11-12 |
Dainippon Pharmaceutical Co |
Procedimiento para preparar compuestos derivados del acido 2-(1-piperazinil)-5-oxopirido-(2,3-d)pirimidino-6-carboxilico y sus sales farmaceuticamente aceptables
|
US3862189A
(en)
|
1973-08-14 |
1975-01-21 |
Warner Lambert Co |
Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
|
US3936454A
(en)
|
1973-08-14 |
1976-02-03 |
Warner-Lambert Company |
5-Amino-4-chloro-6-(substituted amino)-pyrimidines
|
DK3375A
(pt)
|
1974-01-25 |
1975-09-15 |
Ciba Geigy Ag |
|
JPS587626B2
(ja)
|
1974-02-13 |
1983-02-10 |
大日本製薬株式会社 |
ナフチリジン オヨビ キノリンユウドウタイノセイホウ
|
JPS50111080U
(pt)
|
1974-02-21 |
1975-09-10 |
|
|
JPS5625234Y2
(pt)
|
1976-01-17 |
1981-06-15 |
|
|
JPS5359663A
(en)
|
1976-11-09 |
1978-05-29 |
Sumitomo Chem Co Ltd |
2-halogeno methyl indole derivatives and process for praparation of the same
|
JPS52106897A
(en)
|
1977-01-10 |
1977-09-07 |
Dainippon Pharmaceut Co Ltd |
Synthesis of piperazine derivatives
|
JPS5392767A
(en)
|
1977-01-27 |
1978-08-15 |
Sumitomo Chem Co Ltd |
Preparation of 2-phthalimidomethylindole derivatives
|
JPS5625234A
(en)
|
1979-08-02 |
1981-03-11 |
Hitachi Denshi Ltd |
Dropout display system
|
JPS56123981U
(pt)
|
1980-02-20 |
1981-09-21 |
|
|
JPS56123981A
(en)
|
1981-02-23 |
1981-09-29 |
Dainippon Pharmaceut Co Ltd |
Preparation of 1,4-disubstituted piperazine
|
JPS5883698A
(ja)
|
1981-11-13 |
1983-05-19 |
Takeda Chem Ind Ltd |
キノン化合物およびその製造法
|
JPS5883698U
(ja)
|
1981-11-27 |
1983-06-06 |
石川島播磨重工業株式会社 |
熱交換器
|
JPS58162949A
(ja)
|
1982-03-20 |
1983-09-27 |
Konishiroku Photo Ind Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
JPS60140373U
(ja)
|
1984-02-28 |
1985-09-17 |
東洋ハ−ネス株式会社 |
ワイヤハ−ネスのア−ス構造
|
JPS6190153A
(ja)
|
1984-10-09 |
1986-05-08 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の処理方法
|
JPS62103640A
(ja)
|
1985-07-18 |
1987-05-14 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
JPS62103640U
(pt)
|
1985-12-18 |
1987-07-02 |
|
|
JPH07119970B2
(ja)
|
1986-04-18 |
1995-12-20 |
富士写真フイルム株式会社 |
画像形成方法
|
JPS6310746A
(ja)
|
1986-07-01 |
1988-01-18 |
Tanabe Seiyaku Co Ltd |
ナフタレン誘導体
|
CA1324609C
(en)
|
1986-07-30 |
1993-11-23 |
Eastman Kodak Company |
Photographic element and process
|
US4861701A
(en)
|
1987-10-05 |
1989-08-29 |
Eastman Kodak Company |
Photographic element and process comprising a compound which comprises two timing groups in sequence
|
AT388372B
(de)
|
1987-10-08 |
1989-06-12 |
Tanabe Seiyaku Co |
Neue naphthalinderivate und sie enthaltende pharmazeutika
|
JPH01250316A
(ja)
|
1987-12-28 |
1989-10-05 |
Tanabe Seiyaku Co Ltd |
抗脂血剤
|
US5124331A
(en)
|
1988-03-02 |
1992-06-23 |
Yoshitomi Pharmaceutical Industries, Ltd. |
3,4-dihydrothieno[2,3-d]pyrimidine compounds and their pharmaceutical use
|
US5208250A
(en)
|
1988-05-25 |
1993-05-04 |
Warner-Lambert Company |
Known and selected novel arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and anti-inflammatory agents
|
UA27031A1
(uk)
|
1990-04-25 |
2000-02-28 |
Ніссан Кемікал Індастріз Лтд |
Похідhі 3(2h)піридазиhоhу або їх фармацевтичhо прийhятhі солі, що мають протитромботичhу, позитивhу іhотропhу, судиhорозширювальhу дію й аhтиалергічhу активhість та фармацевтичhа композиція hа їх осhові
|
SU1712359A1
(ru)
|
1990-05-07 |
1992-02-15 |
Уфимский Нефтяной Институт |
Гидрохлорид 8 @ -гидроксихинолинового эфира 8-гидроксихинолин-7-карбоновой кислоты, в качестве бактерицида дл подавлени сульфатвосстанавливающих бактерий и культур РSеUDомоNаS и АRтнRовастеR
|
DE69129389T2
(de)
|
1990-06-28 |
1998-10-08 |
Fuji Photo Film Co Ltd |
Photographische Silberhalogenidmaterialien
|
EP0481614A1
(en)
|
1990-10-01 |
1992-04-22 |
Merck & Co. Inc. |
Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists
|
JPH04190232A
(ja)
|
1990-11-26 |
1992-07-08 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料
|
US5480883A
(en)
|
1991-05-10 |
1996-01-02 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
AU1625192A
(en)
|
1991-05-31 |
1992-12-03 |
Zeneca Limited |
Heterocyclic derivatives
|
JP3108483B2
(ja)
|
1991-09-30 |
2000-11-13 |
日清製粉株式会社 |
インドール誘導体およびこれを有効成分とする抗潰瘍薬
|
HUT64064A
(en)
|
1992-02-13 |
1993-11-29 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing puyrido/1,2-a/pyrimidine derivatives and pharmaceutical compositions comprising same as active ingredient
|
US5521184A
(en)
|
1992-04-03 |
1996-05-28 |
Ciba-Geigy Corporation |
Pyrimidine derivatives and processes for the preparation thereof
|
AU3933493A
(en)
|
1992-04-24 |
1993-11-29 |
E.I. Du Pont De Nemours And Company |
Arthropodicidal and fungicidal aminopyrimidines
|
TW229140B
(pt)
|
1992-06-05 |
1994-09-01 |
Shell Internat Res Schappej B V |
|
FR2714907B1
(fr)
|
1994-01-07 |
1996-03-29 |
Union Pharma Scient Appl |
Nouveaux dérivés de l'Adénosine, leurs procédés de préparation, compositions pharmaceutiques les contenant.
|
US6342501B1
(en)
|
1994-02-25 |
2002-01-29 |
The Regents Of The University Of Michigan |
Pyrrolo[2,3-d] pyrimidines as antiviral agents
|
JPH0987282A
(ja)
|
1995-09-21 |
1997-03-31 |
Kyowa Hakko Kogyo Co Ltd |
チアゾール誘導体
|
JPH09176162A
(ja)
|
1995-12-22 |
1997-07-08 |
Toubishi Yakuhin Kogyo Kk |
チアゾリジンジオン誘導体及びその製造法並びにそれを含む医薬組成物
|
JPH09176116A
(ja)
|
1995-12-27 |
1997-07-08 |
Toray Ind Inc |
複素環誘導体およびその医薬用途
|
JPH1025294A
(ja)
|
1996-03-26 |
1998-01-27 |
Akira Matsuda |
縮合ヘテロ環誘導体、その製造法及びそれを含有する悪性腫瘍治療剤
|
EP0934307B1
(en)
|
1996-06-19 |
2011-04-27 |
Aventis Pharma Limited |
Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
|
US6028076A
(en)
|
1996-07-03 |
2000-02-22 |
Japan Energy Corporation |
Purine derivative
|
US5866702A
(en)
|
1996-08-02 |
1999-02-02 |
Cv Therapeutics, Incorporation |
Purine inhibitors of cyclin dependent kinase 2
|
US6630496B1
(en)
|
1996-08-26 |
2003-10-07 |
Genetics Institute Llc |
Inhibitors of phospholipase enzymes
|
JPH10231297A
(ja)
|
1997-02-20 |
1998-09-02 |
Japan Energy Corp |
新規なアデニン−1−n−オキシド誘導体およびその医薬用途
|
CA2309350C
(en)
|
1997-11-12 |
2007-04-03 |
Mitsubishi Chemical Corporation |
Purine derivatives and medicaments comprising the same as active ingredient
|
TW572758B
(en)
|
1997-12-22 |
2004-01-21 |
Sumitomo Pharma |
Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
|
SK12782000A3
(sk)
|
1998-02-25 |
2001-04-09 |
Genetics Institute, Inc. |
Inhibítory fosfolipázových enzýmov, farmaceutický prostriedok s ich obsahom a ich použitie
|
US6828344B1
(en)
|
1998-02-25 |
2004-12-07 |
Genetics Institute, Llc |
Inhibitors of phospholipase enzymes
|
CA2322161A1
(en)
|
1998-02-25 |
1999-09-02 |
Yibin Xiang |
Inhibitors of phospholipase enzymes
|
US6479487B1
(en)
|
1998-02-26 |
2002-11-12 |
Aventis Pharmaceuticals Inc. |
6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
|
CA2330756C
(en)
|
1998-05-04 |
2007-10-02 |
Asta Medica Aktiengesellschaft |
Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation
|
EP1086950B1
(en)
|
1998-05-26 |
2010-09-29 |
Chugai Seiyaku Kabushiki Kaisha |
Heterocyclic indole derivatives and mono- or diazaindole derivatives
|
JP3997651B2
(ja)
|
1998-06-24 |
2007-10-24 |
コニカミノルタホールディングス株式会社 |
新規色素及び画像記録材料及び感熱転写材料及びインクジェット記録液
|
DE69942097D1
(de)
|
1998-08-11 |
2010-04-15 |
Novartis Ag |
Isochinoline derivate mit angiogenesis-hemmender wirkung
|
AU4963999A
(en)
|
1998-08-25 |
2000-03-14 |
Uab Research Foundation, The |
Inhibitors of bacterial nad synthetase
|
US6133031A
(en)
|
1999-08-19 |
2000-10-17 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of focal adhesion kinase expression
|
RU2001124352A
(ru)
|
1999-02-01 |
2004-02-20 |
Си Ви Терапьютикс, Инк. (Us) |
Пуриновые ингибиторы циклин-зависимой киназы 2 и Ikb-альфа
|
GB9905075D0
(en)
|
1999-03-06 |
1999-04-28 |
Zeneca Ltd |
Chemical compounds
|
JP2000281654A
(ja)
|
1999-03-26 |
2000-10-10 |
Tanabe Seiyaku Co Ltd |
イソキノリン誘導体
|
DE19932571A1
(de)
|
1999-07-13 |
2001-01-18 |
Clariant Gmbh |
Verfahren zur Herstellung von Biarylen unter Palladophosphacyclobutan-Katalyse
|
JP2001151771A
(ja)
|
1999-09-10 |
2001-06-05 |
Kyowa Hakko Kogyo Co Ltd |
含窒素芳香族複素環誘導体
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
US6436965B1
(en)
|
2000-03-02 |
2002-08-20 |
Merck Frosst Canada & Co. |
PDE IV inhibiting amides, compositions and methods of treatment
|
EP1138328A1
(en)
|
2000-03-29 |
2001-10-04 |
Eli Lilly And Company Limited |
Naphthalene derivatives as CNS drugs
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
NZ522783A
(en)
|
2000-06-28 |
2004-07-30 |
Smithkline Beecham P |
Wet milling process for pharmaceuticals with agitator or chamber having nylon with internal lubricant
|
CN1331340A
(zh)
|
2000-06-30 |
2002-01-16 |
上海博德基因开发有限公司 |
一种新的多肽——人拓扑异构酶12.1和编码这种多肽的多核苷酸
|
CN1186326C
(zh)
|
2000-07-05 |
2005-01-26 |
山之内制药株式会社 |
丙-1,3-二酮衍生物
|
FR2814073B1
(fr)
|
2000-09-21 |
2005-06-24 |
Yang Ji Chemical Company Ltd |
Composition pharmaceutique antifongique et/ou antiparasitaire et nouveaux derives de l'indole a titre de principes actifs d'une telle composition
|
DOP2002000334A
(es)
|
2001-02-14 |
2002-08-30 |
Warner Lambert Co |
Pirimidinas biciclicas como inhibidores de metaloproteinasas de matriz
|
SE0100568D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
US7148237B2
(en)
|
2001-03-01 |
2006-12-12 |
Shionogi & Co., Ltd. |
Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
|
UA76977C2
(en)
|
2001-03-02 |
2006-10-16 |
Icos Corp |
Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
|
US20050107400A1
(en)
|
2001-03-30 |
2005-05-19 |
Boyd Leslie F. |
Use of pyrazolopyridines as therapeutic compounds
|
JP4237497B2
(ja)
|
2001-03-30 |
2009-03-11 |
スミスクライン ビーチャム コーポレーション |
ピラゾロピリジン類、その調製方法及びその治療用化合物としての使用
|
DE60204452T2
(de)
|
2001-04-27 |
2005-12-15 |
Smithkline Beecham Corp. |
Pyrazolo[1,5a]Pyridinderivate
|
CZ294535B6
(cs)
|
2001-08-02 |
2005-01-12 |
Ústav Experimentální Botaniky Avčr |
Heterocyklické sloučeniny na bázi N6-substituovaného adeninu, způsoby jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
|
GB0121033D0
(en)
|
2001-08-30 |
2001-10-24 |
Novartis Ag |
Organic compounds
|
US8124625B2
(en)
|
2001-09-14 |
2012-02-28 |
Shionogi & Co., Ltd. |
Method of enhancing the expression of apolipoprotein AI using olefin derivatives
|
DE60230890D1
(de)
|
2001-09-19 |
2009-03-05 |
Aventis Pharma Sa |
Indolizine als kinaseproteinhemmer
|
EP1432710A1
(en)
|
2001-09-26 |
2004-06-30 |
Bayer Pharmaceuticals Corporation |
1, 8-naphthyridine derivatives as antidiabetics
|
ES2309206T3
(es)
|
2001-10-02 |
2008-12-16 |
Smithkline Beecham Corporation |
Compuestos quimicos.
|
ATE335490T1
(de)
|
2001-10-30 |
2006-09-15 |
Novartis Pharma Gmbh |
Staurosporin-derivate als hemmer der flt3- rezeptor-tyrosinkinase-wirkung
|
JP4663233B2
(ja)
|
2001-11-09 |
2011-04-06 |
エンゾン,インコーポレーテッド |
ベンジル脱離系を利用する高分子チオール結合プロドラッグ
|
EP1314733A1
(en)
|
2001-11-22 |
2003-05-28 |
Aventis Pharma Deutschland GmbH |
Indole-2-carboxamides as factor Xa inhibitors
|
JP4597519B2
(ja)
|
2001-12-06 |
2010-12-15 |
メルク・シャープ・エンド・ドーム・コーポレイション |
有糸***キネシン阻害薬
|
AU2002357043B2
(en)
|
2001-12-06 |
2008-04-24 |
Merck Sharp & Dohme Corp. |
Mitotic kinesin inhibitors
|
TW200301135A
(en)
|
2001-12-27 |
2003-07-01 |
Otsuka Maryland Res Inst Inc |
Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor
|
EP1484320A1
(en)
|
2002-02-13 |
2004-12-08 |
Takeda Chemical Industries, Ltd. |
Jnk inhibitor
|
AU2003225668A1
(en)
|
2002-03-01 |
2003-09-16 |
Pintex Pharmaceutical, Inc. |
Pin1-modulating compounds and methods of use thereof
|
AU2003222106A1
(en)
|
2002-04-03 |
2003-10-20 |
Bristol-Myers Squibb Company |
Thiopene-based tricyclic compounds and pharmaceutical compositions comprising same
|
MXPA04010983A
(es)
|
2002-05-06 |
2005-02-14 |
Genelabs Tech Inc |
Derivados de nucleosidos para tratar infecciones por el virus de la hepatitis c.
|
PE20040522A1
(es)
|
2002-05-29 |
2004-09-28 |
Novartis Ag |
Derivados de diarilurea dependientes de la cinasa de proteina
|
GB0215676D0
(en)
|
2002-07-05 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
AU2003257822A1
(en)
|
2002-08-13 |
2004-04-30 |
Shionogi And Co., Ltd. |
Heterocyclic compound having hiv integrase inhibitory activity
|
JP4190232B2
(ja)
|
2002-08-26 |
2008-12-03 |
富士通株式会社 |
機械研磨を行う方法
|
BR0314761A
(pt)
|
2002-09-27 |
2005-07-26 |
Sumitomo Pharma |
Composto de adenina e seu uso
|
TWI335913B
(en)
|
2002-11-15 |
2011-01-11 |
Vertex Pharma |
Diaminotriazoles useful as inhibitors of protein kinases
|
AU2003295776B2
(en)
|
2002-11-21 |
2011-05-12 |
Novartis Vaccines And Diagnostics, Inc. |
2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer
|
EP1568688B1
(en)
|
2002-11-25 |
2011-08-31 |
Mochida Pharmaceutical Co., Ltd. |
Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient
|
UA80767C2
(en)
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
CA2512000C
(en)
|
2002-12-26 |
2011-08-09 |
Eisai Co., Ltd. |
Selective estrogen receptor modulator
|
CZ294538B6
(cs)
|
2002-12-30 |
2005-01-12 |
Ústav Experimentální Botaniky Akademie Vědčeské Re |
Substituční deriváty N6-benzyladenosinu, způsob jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
|
RU2233842C1
(ru)
|
2003-01-13 |
2004-08-10 |
Петров Владимир Иванович |
Производные пурина, обладающие противовирусной активностью
|
AR043692A1
(es)
|
2003-02-06 |
2005-08-10 |
Novartis Ag |
2-cianopirrolopirimidinas y sus usos farmaceuticos
|
GB0304640D0
(en)
|
2003-02-28 |
2003-04-02 |
Novartis Ag |
Organic compounds
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
SE0300908D0
(sv)
|
2003-03-31 |
2003-03-31 |
Astrazeneca Ab |
Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
|
US7129264B2
(en)
|
2003-04-16 |
2006-10-31 |
Bristol-Myers Squibb Company |
Biarylmethyl indolines and indoles as antithromboembolic agents
|
EP1619948A4
(en)
|
2003-05-05 |
2007-02-14 |
Neurogen Corp |
SUBSTITUTED IMIDAZOLOPYRAZINE AND TRIAZOLOPYRAZINE DERIVATIVES: GABAA RECEPTOR LIGANDS
|
US7326711B2
(en)
|
2003-06-20 |
2008-02-05 |
Chiron Corporation |
Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
JP4570015B2
(ja)
|
2003-07-14 |
2010-10-27 |
クミアイ化学工業株式会社 |
2−イソオキサゾリン誘導体及びそれを有効成分として含有する除草剤
|
AU2004264419B2
(en)
|
2003-08-15 |
2009-01-15 |
Irm Llc |
6-substituted anilino purines as RTK inhibitors
|
WO2005028434A2
(en)
|
2003-09-18 |
2005-03-31 |
Conforma Therapeutics Corporation |
Novel heterocyclic compounds as hsp90-inhibitors
|
CA2539853C
(en)
|
2003-09-23 |
2011-04-19 |
Merck & Co., Inc. |
Isoquinolinone potassium channel inhibitors
|
AR045944A1
(es)
|
2003-09-24 |
2005-11-16 |
Novartis Ag |
Derivados de isoquinolina 1.4-disustituidas
|
WO2005074603A2
(en)
|
2004-02-03 |
2005-08-18 |
Abbott Laboratories |
Aminobenzoxazoles as therapeutic agents
|
EP1717238A4
(en)
|
2004-02-16 |
2008-03-05 |
Daiichi Seiyaku Co |
FUNGICIDES HETEROCYCLIC COMPOUNDS
|
WO2005091857A2
(en)
|
2004-03-12 |
2005-10-06 |
Bayer Pharmaceuticals Corporation |
1,6-naphthyridine and 1,8-naphthyridine derivatives and their use to treat diabetes and related disorders
|
CN1560035A
(zh)
|
2004-03-12 |
2005-01-05 |
沈阳药科大学 |
5-羟基吲哚-3-羧酸脂类衍生物
|
WO2005092892A1
(ja)
|
2004-03-26 |
2005-10-06 |
Dainippon Sumitomo Pharma Co., Ltd. |
8−オキソアデニン化合物
|
CN1972945A
(zh)
|
2004-04-02 |
2007-05-30 |
腺苷治疗有限责任公司 |
A2a腺苷受体的选择性拮抗剂
|
CN101031569B
(zh)
|
2004-05-13 |
2011-06-22 |
艾科斯有限公司 |
作为人磷脂酰肌醇3-激酶δ抑制剂的喹唑啉酮
|
US20060074102A1
(en)
|
2004-05-14 |
2006-04-06 |
Kevin Cusack |
Kinase inhibitors as therapeutic agents
|
UA84954C2
(ru)
|
2004-07-22 |
2008-12-10 |
Astrazeneca Ab |
Конденсированные пиримидоны, пригодные для лечения и профилактики злокачественного новообразования
|
JP2008509977A
(ja)
|
2004-08-18 |
2008-04-03 |
アストラゼネカ アクチボラグ |
癌の処置及び予防における選択された縮合複素環の鏡像異性体及びその使用
|
DE102004044221A1
(de)
|
2004-09-14 |
2006-03-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
CN101233115A
(zh)
|
2004-10-19 |
2008-07-30 |
诺华疫苗和诊断公司 |
吲哚和苯并咪唑衍生物
|
EP1807417A2
(en)
|
2004-11-04 |
2007-07-18 |
Neurogen Corporation |
Pyrazolylmethyl heteroaryl derivatives
|
JP2008520744A
(ja)
|
2004-11-19 |
2008-06-19 |
ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア |
抗炎症性ピラゾロピリミジン
|
JP2008520612A
(ja)
|
2004-11-24 |
2008-06-19 |
ノバルティス アクチエンゲゼルシャフト |
JAK阻害剤およびBcr−Abl、Flt−3、FAKまたはRAFキナーゼ阻害剤のうち少なくとも1個の組合せ
|
AU2006214190A1
(en)
|
2005-02-17 |
2006-08-24 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
ATE474829T1
(de)
|
2005-06-27 |
2010-08-15 |
Amgen Inc |
Entzündungshemmende arylnitrilverbindungen
|
FR2889192A1
(fr)
|
2005-07-27 |
2007-02-02 |
Cytomics Systems Sa |
Composes antifongiques, compositions contenant ces composes et leurs utilisations
|
JP2009504769A
(ja)
|
2005-08-16 |
2009-02-05 |
ジェンザイム・コーポレーション |
ケモカイン受容体結合化合物
|
US7642270B2
(en)
|
2005-09-14 |
2010-01-05 |
Janssen Pharmaceutica N.V. |
5-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinase
|
EP1939202A4
(en)
|
2005-09-22 |
2010-06-16 |
Dainippon Sumitomo Pharma Co |
NEW COMPOUND OF ADENINE
|
GB0520657D0
(en)
*
|
2005-10-11 |
2005-11-16 |
Ludwig Inst Cancer Res |
Pharmaceutical compounds
|
CA2628283C
(en)
|
2005-11-01 |
2017-06-27 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
EP1783114A1
(en)
|
2005-11-03 |
2007-05-09 |
Novartis AG |
N-(hetero)aryl indole derivatives as pesticides
|
WO2007059108A2
(en)
|
2005-11-10 |
2007-05-24 |
Chemocentryx, Inc. |
Substituted quinolones and methods of use
|
DK2348023T5
(da)
|
2005-12-13 |
2017-05-15 |
Incyte Holdings Corp |
Heteroaryl-substituerede pyrrolo[2,3-b]pyridiner og pyrrolo[2,3-b]pyrimidiner som Janus-kinase-inhibitorer
|
US7989461B2
(en)
|
2005-12-23 |
2011-08-02 |
Amgen Inc. |
Substituted quinazolinamine compounds for the treatment of cancer
|
US20100227880A1
(en)
|
2006-01-25 |
2010-09-09 |
Kristjan Gudmundsson |
Chemical compounds
|
PE20071025A1
(es)
|
2006-01-31 |
2007-10-17 |
Mitsubishi Tanabe Pharma Corp |
Compuesto amina trisustituido
|
PE20070978A1
(es)
|
2006-02-14 |
2007-11-15 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
|
US20090069304A1
(en)
|
2006-03-03 |
2009-03-12 |
Shionogi & Co., Ltd. |
Mmp-13 selective inhibitor
|
BRPI0709699A2
(pt)
|
2006-03-29 |
2011-07-26 |
Foldrx Pharmaceuticals Inc |
inibiÇço da toxidez da alfa-sinucleina
|
KR20150038395A
(ko)
*
|
2006-04-04 |
2015-04-08 |
더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 |
키나제 길항물질
|
DE102006029074A1
(de)
*
|
2006-06-22 |
2007-12-27 |
Friedrich-Schiller-Universität Jena |
4-Amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidin-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung als antivirale Wirkstoffe
|
US8933130B2
(en)
|
2006-06-23 |
2015-01-13 |
Radius Health, Inc. |
Treatment of vasomotor symptoms with selective estrogen receptor modulators
|
US20080004253A1
(en)
|
2006-06-30 |
2008-01-03 |
Bryan James Branstetter |
Thiazolopyrimidine modulators of TRPV1
|
US20080009508A1
(en)
|
2006-07-10 |
2008-01-10 |
Lucie Szucova |
6,9-Disubstituted Purine Derivatives And Their Use For Treating Skin
|
EP2046788A1
(en)
|
2006-07-12 |
2009-04-15 |
Syngeta Participations AG |
Triazolopyridine derivatives as herbicides
|
WO2008018426A1
(fr)
|
2006-08-08 |
2008-02-14 |
Chugai Seiyaku Kabushiki Kaisha |
Dérivé de pyrimidine comme inhibiteur de la PI3K et son utilisation
|
JP5336375B2
(ja)
|
2006-08-30 |
2013-11-06 |
セルゾーム リミテッド |
キナーゼ阻害剤としてのトリアゾール誘導体
|
WO2008032033A1
(en)
|
2006-09-14 |
2008-03-20 |
Astrazeneca Ab |
4-benzimidazolyl-2-morpholino-6-piperazinylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
|
EP1972631A1
(en)
|
2007-03-23 |
2008-09-24 |
Novartis AG |
Imidazopyridazines as PI3K lipid kinase inhibitors
|
WO2008055013A2
(en)
|
2006-10-31 |
2008-05-08 |
Janssen Pharmaceutica N.V. |
5-oxo-5,8 - dihydro - pyrido - pyrimidines as inhibitors of c-fms kinase
|
AU2007323836B2
(en)
|
2006-11-13 |
2013-04-18 |
Icos Corporation |
Thienopyrimidinones for treatment of inflammatory disorders and cancers
|
MY188338A
(en)
|
2006-11-22 |
2021-11-30 |
Incyte Holdings Corp |
Imidazotriazines and imidazopyrimidines as kinase inhibitors
|
CA2672960A1
(en)
|
2006-12-20 |
2008-07-10 |
Schering Corporation |
Novel jnk inhibitors
|
DE602007010359D1
(de)
|
2006-12-29 |
2010-12-16 |
Hoffmann La Roche |
Azaspiroderivate
|
CL2008000369A1
(es)
|
2007-02-05 |
2008-04-18 |
Xenon Pharmaceuticals Inc |
Compuestos derivados de piridopirimidinonas; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar dolor, depresion, enfermedades cardiovasculares, enfermedades respiratorias y enfermedades psiquiatricas.
|
US20090047246A1
(en)
|
2007-02-12 |
2009-02-19 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
TW200902018A
(en)
|
2007-03-20 |
2009-01-16 |
Dainippon Sumitomo Pharma Co |
Novel adenine compound
|
US20080233127A1
(en)
|
2007-03-21 |
2008-09-25 |
Wyeth |
Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors
|
PT2137186E
(pt)
|
2007-03-23 |
2016-03-30 |
Amgen Inc |
Compostos heterocíclicos e suas utilizações
|
AU2008231384B2
(en)
|
2007-03-23 |
2011-09-15 |
Amgen Inc. |
Heterocyclic compounds and their use
|
US8039505B2
(en)
|
2007-04-11 |
2011-10-18 |
University Of Utah Research Foundation |
Compounds for modulating T-cells
|
US9603848B2
(en)
|
2007-06-08 |
2017-03-28 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
EP2167058B1
(en)
|
2007-06-18 |
2015-08-12 |
University Of Louisville Research Foundation, Inc. |
Family of pfkfb3 inhibitors with anti-neoplastic activities
|
KR101561710B1
(ko)
|
2007-06-29 |
2015-10-19 |
길리애드 사이언시즈, 인코포레이티드 |
퓨린 유도체 및 그것의 톨 유사 수용체 7의 조절 인자로서 용도
|
US20090053192A1
(en)
|
2007-08-10 |
2009-02-26 |
Burnham Institute For Medical Research |
Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof
|
TW200916447A
(en)
|
2007-08-29 |
2009-04-16 |
Methylgene Inc |
Sirtuin inhibitors
|
JP2009076865A
(ja)
|
2007-08-29 |
2009-04-09 |
Fujifilm Corp |
有機電界発光素子
|
WO2009034386A1
(en)
|
2007-09-13 |
2009-03-19 |
Astrazeneca Ab |
Derivatives of adenine and 8-aza-adenine and uses thereof-796
|
JP2009080233A
(ja)
|
2007-09-26 |
2009-04-16 |
Kyocera Mita Corp |
電子写真感光体
|
CZ300774B6
(cs)
|
2007-10-05 |
2009-08-05 |
Univerzita Palackého |
Substituované 6-(alkylbenzylamino)purinové deriváty pro použití jako antagonisté cytokininových receptoru a prípravky obsahující tyto slouceniny
|
EP2217239A2
(en)
|
2007-11-07 |
2010-08-18 |
Foldrx Pharmaceuticals, Inc. |
Modulation of protein trafficking
|
WO2009063235A1
(en)
|
2007-11-13 |
2009-05-22 |
Astrazeneca Ab |
Derivatives of 1,9-dihydro-6h-purin-6-one and uses thereof-018
|
JP2009120686A
(ja)
|
2007-11-14 |
2009-06-04 |
Toyo Ink Mfg Co Ltd |
光重合開始剤、重合性組成物、および重合物の製造方法。
|
CL2008003798A1
(es)
|
2007-12-19 |
2009-10-09 |
Amgen Inc |
Compuestos derivados de heterobiciclos aromaticos sustituidos, inhibidores de pi3 quinasa; composicion farmaceutica; utiles en el tratamiento de cancer, melanomas, glioblastomas, entre otras enfermedades.
|
AU2008345225A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
JP2011507900A
(ja)
|
2007-12-21 |
2011-03-10 |
ワイス・エルエルシー |
イミダゾ[1,2−a]ピリジン化合物
|
EP2231641B1
(en)
|
2007-12-21 |
2016-06-01 |
UCB Biopharma SPRL |
Quinoxaline and quinoline derivatives as kinase inhibitors
|
BRPI0722222A2
(pt)
|
2007-12-28 |
2015-06-16 |
Topharman Shangai Co Ltd |
N-{1-[3-(2-etóxi-5-(4-etilpiperazinil)sulfonilfenil)-4,5-di hidro-5-oxo-1,2,4-triazina-6-il]etil}butiramida, seu método de preparo e seu uso
|
US7960397B2
(en)
|
2007-12-28 |
2011-06-14 |
Institute Of Experimental Botany, Academy Of Sciences Of The Czech Republic |
6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
|
US8193182B2
(en)
*
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
EA201070841A1
(ru)
|
2008-01-11 |
2011-02-28 |
Натко Фарма Лимитед |
НОВЫЕ ПИРАЗОЛО[3,4-d]ПИРИМИДИНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ПРОТИВОРАКОВЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ
|
US9089572B2
(en)
|
2008-01-17 |
2015-07-28 |
California Institute Of Technology |
Inhibitors of p97
|
WO2009097446A1
(en)
|
2008-01-30 |
2009-08-06 |
Genentech, Inc. |
Pyrazolopyrimidine pi3k inhibitor compounds and methods of use
|
EP2444403A1
(en)
|
2008-04-18 |
2012-04-25 |
Shionogi Co., Ltd. |
Heterocyclic compound having inhibitory activity on PI3K
|
US8119647B2
(en)
|
2008-04-23 |
2012-02-21 |
Glenmark Pharmaceuticals S.A. |
Fused pyrimidineone compounds as TRPV3 modulators
|
WO2009140215A2
(en)
|
2008-05-11 |
2009-11-19 |
Geraghty, Erin |
Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds
|
US10301265B2
(en)
|
2008-05-28 |
2019-05-28 |
Virginia I. Roxas-Duncan |
Small molecule inhibitors of botulinum neurotoxins
|
US20110294836A1
(en)
|
2008-06-20 |
2011-12-01 |
Metabolex, Inc. |
Aryl gpr119 agonists and uses thereof
|
US8026271B2
(en)
|
2008-07-11 |
2011-09-27 |
National Health Research Institutes |
Formulations of indol-3-yl-2-oxoacetamide compounds
|
WO2010018458A2
(en)
|
2008-08-12 |
2010-02-18 |
Crystalgenomics, Inc. |
Phenol derivatives and methods of use thereof
|
JP5731978B2
(ja)
|
2008-09-26 |
2015-06-10 |
インテリカイン, エルエルシー |
複素環キナーゼ阻害剤
|
KR20160091440A
(ko)
|
2008-11-13 |
2016-08-02 |
길리아드 칼리스토가 엘엘씨 |
혈액 종양에 대한 요법
|
WO2010075068A1
(en)
|
2008-12-16 |
2010-07-01 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
AR075111A1
(es)
|
2008-12-24 |
2011-03-09 |
Bial Portela & Ca Sa |
Derivados heterociclicos de diazoles y triazoles, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de trastornos del metabolismo y del sistema nervioso, entre otros.
|
WO2010083444A1
(en)
|
2009-01-15 |
2010-07-22 |
Anvyl, Llc |
Alpha7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof
|
US8513284B2
(en)
|
2009-02-13 |
2013-08-20 |
Ucb Pharma, S.A. |
Fused pyridine and pyrazine derivatives as kinase inhibitors
|
TW201100428A
(en)
|
2009-03-31 |
2011-01-01 |
Arqule Inc |
Substituted indolo-piperidine compounds
|
WO2010118367A2
(en)
|
2009-04-10 |
2010-10-14 |
Progenics Pharmaceuticals, Inc. |
Antiviral pyrimidines
|
KR20120005523A
(ko)
|
2009-04-20 |
2012-01-16 |
길리아드 칼리스토가 엘엘씨 |
고형 종양의 치료 방법
|
WO2010127208A1
(en)
|
2009-04-30 |
2010-11-04 |
Forest Laboratories Holdings Limited |
Inhibitors of acetyl-coa carboxylase
|
EP2427195B1
(en)
|
2009-05-07 |
2019-05-01 |
Intellikine, LLC |
Heterocyclic compounds and uses thereof
|
AU2010249380B2
(en)
|
2009-05-22 |
2015-08-20 |
Incyte Holdings Corporation |
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as Janus kinase inhibitors
|
MX2011013510A
(es)
*
|
2009-06-25 |
2012-03-07 |
Amgen Inc |
Compuestos heterociclicos y sus usos.
|
WO2010151735A2
(en)
|
2009-06-25 |
2010-12-29 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
AR077280A1
(es)
|
2009-06-29 |
2011-08-17 |
Incyte Corp |
Pirimidinonas como inhibidores de pi3k, y composiciones farmaceuticas que los comprenden
|
KR101712035B1
(ko)
|
2009-06-29 |
2017-03-03 |
아지오스 파마슈티컬스 아이엔씨. |
치료용 화합물 및 조성물
|
FR2947269B1
(fr)
|
2009-06-29 |
2013-01-18 |
Sanofi Aventis |
Nouveaux composes anticancereux
|
AR077252A1
(es)
|
2009-06-29 |
2011-08-10 |
Xenon Pharmaceuticals Inc |
Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
|
CN102647987A
(zh)
|
2009-07-21 |
2012-08-22 |
吉里德卡利斯托加公司 |
使用pi3k抑制剂治疗肝脏障碍
|
PL2470546T3
(pl)
|
2009-08-28 |
2013-12-31 |
Takeda Pharmaceuticals Co |
Związki heksahydrooksazynopterydynowe do zastosowania jako inhibitory MTOR
|
US9249145B2
(en)
|
2009-09-01 |
2016-02-02 |
Incyte Holdings Corporation |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
US9242987B2
(en)
|
2009-10-20 |
2016-01-26 |
Cellzome Limited |
Heterocyclyl pyrazolopyrimidine analogues as JAK inhibitors
|
IN2012DN02984A
(pt)
|
2009-10-22 |
2015-07-31 |
Gilead Sciences Inc |
|
EA036876B1
(ru)
*
|
2009-11-05 |
2020-12-30 |
Ризен Фармасьютикалз С.А. |
Ингибиторы pi3k киназы
|
CU24077B1
(es)
|
2009-11-10 |
2015-03-30 |
Pfizer |
DERIVADOS DE N1-PIRAZOLOESPIROCETONA ÚTILES COMO INHIBIDORES DE ACETIL-CoA CARBOXILASA
|
WO2011058111A1
(en)
|
2009-11-12 |
2011-05-19 |
Ucb Pharma S.A. |
Aminopurine derivatives as kinase inhibitors
|
US8957090B2
(en)
|
2009-11-12 |
2015-02-17 |
Ucb Pharma S.A. |
Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors
|
EP2511283A4
(en)
|
2009-12-10 |
2013-07-03 |
Inst Materia Medica Cams |
N6-SUBSTITUTED ADENOSINE DERIVATIVES, N6-SUBSTITUTED ADENINE DERIVATIVES AND THEIR USE
|
AR079529A1
(es)
|
2009-12-18 |
2012-02-01 |
Incyte Corp |
Derivados arilo y heteroarilo sustituidos y fundidos como inhibidores de la pi3k
|
US8759359B2
(en)
|
2009-12-18 |
2014-06-24 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as PI3K inhibitors
|
AU2010330875B2
(en)
|
2009-12-18 |
2013-08-01 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
MX345142B
(es)
*
|
2009-12-23 |
2017-01-18 |
Palau Pharma Sa |
Derivados de aminoalquilpirimidina como antagonistas del receptor h4 de histamina.
|
JP2011136925A
(ja)
|
2009-12-28 |
2011-07-14 |
Dainippon Sumitomo Pharma Co Ltd |
含窒素二環性化合物
|
UA109780C2
(uk)
|
2010-01-07 |
2015-10-12 |
ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі |
ТІАЗОЛО[5,4-d]ПІРИМІДИНИ І ЇХ ЗАСТОСУВАННЯ ЯК АГРОХІМІЧНИХ ЗАСОБІВ
|
UY33199A
(es)
|
2010-01-26 |
2011-08-31 |
Boehringer Ingelheim Int |
5-alquinil-pirimidinas.
|
SI3354652T1
(sl)
|
2010-03-10 |
2020-08-31 |
Incyte Holdings Corporation |
Derivati piperidin-4-il azetidina kot inhibitorji JAK1
|
CA2789900A1
(en)
|
2010-03-22 |
2011-09-29 |
Glenmark Pharmaceuticals S.A. |
Pharmaceutical composition comprising a pyrimidineone derivative
|
UY33304A
(es)
|
2010-04-02 |
2011-10-31 |
Amgen Inc |
Compuestos heterocíclicos y sus usos
|
WO2011130342A1
(en)
|
2010-04-14 |
2011-10-20 |
Incyte Corporation |
FUSED DERIVATIVES AS ΡI3Κδ INHIBITORS
|
CA2799579A1
(en)
|
2010-05-21 |
2011-11-24 |
Intellikine, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
AU2011265258A1
(en)
|
2010-06-11 |
2013-01-10 |
Calistoga Pharmaceuticals, Inc. |
Methods of treating hematological disorders with quinazolinone compounds in selected patients
|
US9062055B2
(en)
|
2010-06-21 |
2015-06-23 |
Incyte Corporation |
Fused pyrrole derivatives as PI3K inhibitors
|
AU2011272853A1
(en)
|
2010-07-01 |
2013-01-10 |
Amgen Inc. |
Heterocyclic compounds and their use as inhibitors of PI3K activity
|
WO2012003262A1
(en)
|
2010-07-01 |
2012-01-05 |
Amgen Inc. |
Heterocyclic compounds and their use as inhibitors of pi3k activity
|
WO2012003271A1
(en)
|
2010-07-02 |
2012-01-05 |
Amgen Inc. |
Heterocyclic compounds and their use as inhibitors of pi3k activity
|
CA2812467A1
(en)
|
2010-09-24 |
2012-03-29 |
Gilead Calistoga Llc |
Atropisomers of pi3k-inhibiting compounds
|
MX2013005005A
(es)
|
2010-11-04 |
2013-10-25 |
Amgen Inc |
Derivados de ciano-4,6-diaminopirimidina o 6-aminopurina como inhibidores de pi3k-delta.
|
JP2013545749A
(ja)
|
2010-11-10 |
2013-12-26 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
複素環化合物及びその使用
|
MX2013005567A
(es)
|
2010-11-17 |
2013-10-30 |
Amgen Inc |
Derivados de quinolina como inhibidores de pik3.
|
JP5917545B2
(ja)
|
2010-11-19 |
2016-05-18 |
インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation |
Jak阻害剤としてのシクロブチル置換ピロロピリジンおよびピロロピリミジン誘導体
|
US9034884B2
(en)
|
2010-11-19 |
2015-05-19 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors
|
US20140018540A1
(en)
|
2010-12-14 |
2014-01-16 |
Electrophoretics Limited |
Casein kinase 1delta (ck 1delta) inhibitors
|
ES2764848T3
(es)
|
2010-12-20 |
2020-06-04 |
Incyte Holdings Corp |
N-(1-(fenilo sustituido)etilo)-9H-purina-6-aminas como inhibidores de PI3K
|
JP2014501261A
(ja)
|
2010-12-23 |
2014-01-20 |
アムジエン・インコーポレーテツド |
複素環化合物およびそれらの使用
|
SG10201600179RA
(en)
|
2011-01-10 |
2016-02-26 |
Infinity Pharmaceuticals Inc |
Processes for preparing isoquinolinones and solid forms of isoquinolinones
|
EP2670733B1
(en)
|
2011-02-01 |
2019-04-10 |
The Board of Trustees of the University of Illionis |
N-hydroxybenzamide derivatives as hdac inhibitors and therapeutic methods using the same
|
WO2012125629A1
(en)
|
2011-03-14 |
2012-09-20 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
|
US9126948B2
(en)
|
2011-03-25 |
2015-09-08 |
Incyte Holdings Corporation |
Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
|
EA201490042A1
(ru)
|
2011-06-20 |
2014-10-30 |
Инсайт Корпорейшн |
Азетидинил-фенил-, пиридил- или пиразинилкарбоксамидные производные как ингибиторы jak
|
US8969363B2
(en)
|
2011-07-19 |
2015-03-03 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為jak抑制劑之環己基氮雜環丁烷衍生物
|
PE20181272A1
(es)
*
|
2011-09-02 |
2018-08-03 |
Incyte Holdings Corp |
Heterociclilaminas como inhibidores de pi3k
|
US20140235643A1
(en)
|
2011-10-04 |
2014-08-21 |
Gilead Calistoga Llc |
Novel quinoxaline inhibitors of pi3k
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
AR091079A1
(es)
|
2012-05-18 |
2014-12-30 |
Incyte Corp |
Derivados de pirrolopirimidina y pirrolopiridina sustituida con piperidinilciclobutilo como inhibidores de jak
|
KR20150074193A
(ko)
|
2012-11-01 |
2015-07-01 |
인사이트 코포레이션 |
Jak 억제제로서 트리사이클릭 융합된 티오펜 유도체
|
TWI736135B
(zh)
|
2013-03-01 |
2021-08-11 |
美商英塞特控股公司 |
吡唑并嘧啶衍生物治療PI3Kδ相關病症之用途
|
KR102377688B1
(ko)
|
2013-03-15 |
2022-03-22 |
얀센 파마슈티카 엔.브이. |
약제를 제조하기 위한 방법 및 중간체
|
SI3527263T1
(sl)
|
2013-05-17 |
2021-05-31 |
Incyte Corporation |
Derivati bipirazola kot zaviralci JAK
|
US10077277B2
(en)
|
2014-06-11 |
2018-09-18 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
|
AR103297A1
(es)
|
2014-12-30 |
2017-05-03 |
Forma Therapeutics Inc |
Pirrolo y pirazolopirimidinas como inhibidores de la proteasa 7 específica de ubiquitina
|
CR20210055A
(es)
|
2015-02-27 |
2021-04-27 |
Incyte Corp |
SALES DE IHNIBIDOR DE PI3K Y PROCESOS DE PREPARACIÓN (Divisional 2017-0389)
|
WO2016183062A1
(en)
|
2015-05-11 |
2016-11-17 |
Incyte Corporation |
Salts of (s)-7-(1-(9h-purin-6-ylamino)ethyl)-6-(3-fluorophenyl)-3-methyl-5h-thiazolo[3,2-a]pyrimidin-5-one
|
US9988401B2
(en)
|
2015-05-11 |
2018-06-05 |
Incyte Corporation |
Crystalline forms of a PI3K inhibitor
|
WO2016183060A1
(en)
|
2015-05-11 |
2016-11-17 |
Incyte Corporation |
Process for the synthesis of a phosphoinositide 3-kinase inhibitor
|
CA3101323A1
(en)
|
2018-06-01 |
2019-12-05 |
Incyte Corporation |
Dosing regimen for the treatment of pi3k related disorders
|